Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1 clinical trials
A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190

The GLA enzyme is ubiquitously expressed throughout the body and is responsible for the breakdown of glycosphingolipids, deficiency of which results in the accumulation of specific glycosphingolipids that are associated with the pathophysiology of the disease.

breakdown
gene therapy
deficiency
glycosphingolipids
fabry's disease
  • 0 views
  • 19 Feb, 2024